Company Overview and News

1
Multiple Tailwinds Aid Canadian Pacific: Retain Stock for now

2018-09-21 zacks
We have issued an updated research report on Canadian Pacific Railway Limited (CP - Free Report) on Sep 20.
ODFL CP CP ARCB UTX TRTN ODLF EOG

4
CANADA STOCKS-TSX pushed higher by materials, healthcare stocks

2018-09-19 reuters - 1
Sept 19 (Reuters) - Canada’s main stock index gained ground on Wednesday as the materials group got a boost from higher gold prices and as the healthcare sector rose, led by cannabis producers.
ACB CP CP IFSPF WEED ACBFF CFPZF CGC

1
CP / Canadian Pacific Railway Ltd. 8-K (Current Report)

2018-09-19 sec.gov - 1
Document UNITED STATES SECU
CP

2
Will High Operating Expenses Mar FedEx's (FDX) Q1 Earnings?

2018-09-13 zacks
FedEx Corporation (FDX - Free Report) is set to release first-quarter fiscal 2019 results after the closing bell on Sep 17.
CP CP TNTE TNTEY FDX CSX TNTEF DAL

 
Dozens choose death by train each year. Transit agencies are stepping up.

2018-09-13 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
CP CP

 
City of Vancouver may sell 4 blocks of Arbutus Corridor back to CP for $1

2018-09-06 cbc.ca
Staff are proposing to remove four blocks of the Arbutus Corridor — which was bought from Canadian Pacific Railway in 2016 for $55 million — from their development plan, because they "are not required for transportation or greenway purposes."
CP CP

 
Hundreds of so-called ‘trespassers’ have been run over on Canada’s railways. The Transportation Safety Board has only investigated 2

2018-09-05 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
CP CP

15
Canada's CN Rail to buy 60 more locomotives from GE

2018-09-05 reuters
Sept 5 (Reuters) - Canadian National Railway Co said on Wednesday it would buy 60 additional locomotives from General Electric Co to meet growing demand for more shipment capacity.
CP CP GEC GE GNE

100
Tracking Stephen Mandel's Lone Pine Capital Portfolio - Q2 2018 Update

2018-09-04 seekingalpha - 1
Stephen Mandel’s 13F portfolio value decreased ~4% from $19.74B to $18.91B. The number of positions decreased from 30 to 28.
STZ.B FB CP SQNXF NOW PYPL GOOG NVDA ADBE ATVI DLTR CP AMZN AVGO CSX MELI TSM IQV EA SQ WYNN TDG TRU TMUSP TMUS STZ EXAS SE BABA BLK BKNG GOOGL MSFT BRCM MHK UNH SBAC

28
The Zacks Analyst Blog Highlights: Advance Auto, AutoZone, O'Reilly Automotive and CSX

2018-08-29 zacks - 1
Chicago, IL –August 29, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Advance Auto Parts, Inc. (AAP - Free Report) , AutoZone, Inc. (AZO - Free Report) , O'Reilly Automotive, Inc. (ORLY - Free Report) and CSX Corporation (CSX - Free Report) .
ECR CP AZO CP CSX MS GM AAP KSU UNP MPX JOUT HEAR URBN FIVE ORLY

21
4 Top Winners From the US-Mexico Trade Deal

2018-08-28 investorplace - 1
The United States recently reached an agreement with Mexico for a new trade deal. It is called U.S.-Mexico trade pact and will rewrite NAFTA, which also includes Canada. The announcement lifted the broader markets that have for quite some time been weighed down by trade conflicts.
CP UNP AZO CNI CP GM KSU ORLY

1
Canadian Pacific Scales 52-Week High on Favorable Freight

2018-08-28 zacks
Shares of Canadian Pacific Railway Limited (CP - Free Report) hit a 52-week high of $208.33 during the trading session on Aug 27 before retracing a bit to close at $207.69. Moreover, the stock has surged 35.2% in a year, outperforming the industry’s 33.7% growth.
GATX CP CP WCN REGN SKYW GMTA TRN GMT

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to CP / Canadian Pacific Railway Ltd. on message board site Silicon Investor.

Jimbou0027s Playhouse/CPQ Jimbou0027s Playhouse/CPQ Jimbou0027s Playhouse/CPQ Anadarko Petroleum Cp Anadarko Petroleum Cp Anadarko Petroleum Cp
CPI Aerostructures (CVU)- Take a Look (was CPI) CPI Aerostructures (CVU)- Take a Look (was CPI) CPI Aerostructures (CVU)- Take a Look (was CPI) CPE.H - Capital Pro Egaux Inc. CPE.H - Capital Pro Egaux Inc. CPE.H - Capital Pro Egaux Inc.
PCP: Precision Castparts Corp. PCP: Precision Castparts Corp. PCP: Precision Castparts Corp. Celator Pharmaceuticals - CPXX Celator Pharmaceuticals - CPXX Celator Pharmaceuticals - CPXX
NanoTech Entertainment (OTCPINK:NTEK) NanoTech Entertainment (OTCPINK:NTEK) NanoTech Entertainment (OTCPINK:NTEK) Fertilizer African Plays (PCP.V, FED.V) Fertilizer African Plays (PCP.V, FED.V) Fertilizer African Plays (PCP.V, FED.V)
Receptos,Inc. (RCPT) Receptos,Inc. (RCPT) Receptos,Inc. (RCPT) InterCept ICPT InterCept ICPT InterCept ICPT
CUSIP: 13645T100